Navigation Links
Supercomputing equipment to advance the frontiers of computational biology

Researchers at Rensselaer Polytechnic Institute will continue to advance the frontiers of computational science with the help of IBM's Blue Gene supercomputer. Awarded under IBM's Shared University Research (SUR) program, this Blue Gene will complement the $100 million partnership between Rensselaer, IBM, and New York state to create one of the world's most powerful university-based supercomputing centers.

The equipment will provide a resource for scientists to gain experience with the Blue Gene computing environment, while also supporting a project to develop new simulation technologies for understanding biological systems. The work will help researchers develop algorithms and software that run efficiently on Blue Gene technology, which is a key part of the new Computational Center for Nanotechnology Innovations (CCNI).

This $2.23 million gift of IBM equipment counts toward the $1.4 billion Renaissance at Rensselaer campaign.

"This award further advances the strong partnership between IBM and Rensselaer to develop a leading-edge, high-performance computational capability," said Rensselaer President Shirley Ann Jackson. "It will allow our faculty and students to take the lead in research that will enable key nanotechnology innovations in the fields of energy, biotechnology, arts, and medicine."

As biology becomes a more quantitative field, researchers need new simulation technologies to understand how proteins, DNA, and other biological systems behave at the molecular level, according to the Rensselaer research team. The new SUR award is designed to help develop simulations for prototyping medical devices in "virtual patients," with potential applications in targeted drug delivery systems such as drug eluting stents, transdermal patches, and inhalers.

To be successful, these simulations must run efficiently and effectively on the latest generation of high-performance computing equipment. The project will help researcher s develop critical computational biology tools that operate on the Blue Gene system, with the goal of making these available to a broad community of users.

The project's principal investigators at Rensselaer are Angel Garcia, senior constellation chaired professor in biocomputation and bioinformatics; Mark Shephard, the Samuel A. and Elisabeth C. Johnson Jr. Professor of Engineering and director of the Scientific Computation Research Center; Shekhar Garde, the Elaine and Jack S. Parker Career Development Professor of Chemical and Biological Engineering; and Kenneth Jansen, associate professor of mechanical, aerospace, and nuclear engineering.

The new Blue Gene system consists of a single rack with 1,024 dual processor compute nodes, 32 I/O nodes, a service node, a front-end node, and multiple terabytes of SAN-based disk storage.

Announced in May 2006, the Computational Center for Nanotechnology Innovations (CCNI) is a $100 million partnership between Rensselaer, IBM, and New York state to create one of the world's most powerful university-based supercomputing centers, and a top supercomputing center of any kind in the world. The center is designed to help continue the impressive advances in shrinking device dimensions seen by electronics manufacturers, and to enable key nanotechnology innovations in the fields of energy, biotechnology, arts, and medicine. Learn more at the CCNI Web site: http://rpi.edu/research/ccni/index.html.
'"/>

Source:Rensselaer Polytechnic Institute


Related biology news :

1. Aptamer-based Biosensor screens Air Force personnel and equipment
2. A step toward the $1,000 personal genome using readily available lab equipment
3. Research advances quest for HIV-1 vaccine
4. Inexpensive, mass-produced genes core of synthetic biology advances at UH
5. Study of genomic DNA leads to new advances in cancer diagnostics
6. Molecular models advance the fight against malaria
7. Researchers test new therapy for advanced melanoma
8. Agilent Technologies introduces advanced zebrafish, mouse microarrays for stem cell and developmental biology research
9. Major advance made on DNA structure
10. Wild grasses and man-made wheats advance research capabilities
11. Gene therapy advance treats hemophilia in mouse models

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/3/2016)... DUBLIN , Feb. 3, 2016 /PRNewswire/ ... announced the addition of the "Emotion ... NLP, Machine Learning, and Others), Software Tools ... Application Areas, End Users,and Regions - Global ... offering. --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) ...
(Date:2/2/2016)... YORK , Feb. 2, 2016 Technology Enhancements ... presents an analysis of the digital and computed radiography ... Malaysia , and Indonesia ... trends and market size, as well as regional market ... country and discusses market penetration and market attractiveness, both ...
(Date:2/1/2016)... -- Today, the first day of American Heart Month, the ... first of its kind workplace health solution that leverages ... first application of Watson to ... Welltok will create a new offering that combines AHA,s ... on Welltok,s health optimization platform. The effort is intended ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... -- - New FDA action date of July ... date of July 22, 2016   --> ... 2016   - Lifitegrast has the potential ... the treatment of signs and symptoms of dry eye disease in ... be the only product approved in the U.S. in the past decade indicated for the ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... and triple quad LC-MS, host live demos and poster sessions, and present on ... exhibition. The conference takes place March 6 to 10 at the Georgia World ...
(Date:2/4/2016)... 2016 Beike Biotechnology, the Shenzhen ... a ceremony in late 2015 to mark their successful ... 2016. --> --> ... Personalized Cell Therapy" was hosted by the Shenzhen Cell ... subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... MENLO PARK, Calif. , Feb. 4, 2016 ... the "Company"), a biopharmaceutical company focused on the development and ... present at the 18 th Annual BIO CEO ... 10:00 a.m. EST in New York, NY ... CEO, will provide an update on the ongoing clinical trial ...
Breaking Biology Technology: